Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
Sponsored by Alcon Research
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Started 2 years ago
What is this trial about?
What are the Participation Requirements?
Key Inclusion Criteria:
- Subject or legally authorized representative must be able to understand and sign an
approved Informed Consent Form.
- Subject must have had bilateral implantation of Clareon Vivity, Clareon Vivity Toric,
Clareon PanOptix, or Clareon PanOptix Toric IOLs between 3-6 months prior to
enrollment.
- Subject must have a documented medical history and required pre-operative baseline
information available for retrospective data collection.
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria:
- Subject is currently participating in another investigational drug or device study.
- Subject has had corneal refractive surgery after Clareon Vivity, Clareon Vivity Toric,
Clareon PanOptix, or Clareon PanOptix Toric IOL implantation.
- Subject is pregnant at the time of enrollment.
- Other protocol-defined exclusion criteria may apply.